Skip to main content
All lobbying filings

W STRATEGIES, LLC

Lobbying for INCYTE CORPORATION · ​Biopharmaceutical Company.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · $60,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 2
Health Issues

Education around access to innovative therapies in dermatology. Issues related to the 340(b)program.

Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem